Panagora Asset Management Inc Caladrius Biosciences, Inc. Transaction History

Panagora Asset Management Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 12, 2019	SELL	$2.22 - $2.99 $19,986 - $26,918	-9,003 Closed	0 $0
Q2 2019 Aug 09, 2019	SELL	$2.25 - $3.6 $2,794 - $4,471	-1,242 Reduced 12.12%	9,003 $21,000
Q1 2019 May 15, 2019	SELL	$3.48 - $5.32 $5,129 - $7,841	-1,474 Reduced 12.58%	10,245 $37,000
Q4 2018 Feb 14, 2019	SELL	$3.49 - $5.77 $767 - $1,269	-220 Reduced 1.84%	11,719 $42,000
Q3 2018 Nov 13, 2018	SELL	$4.85 - $6.5 $5,679 - $7,611	-1,171 Reduced 8.93%	11,939 $70,000
Q2 2018 Aug 14, 2018	SELL	$3.8 - $8.64 $30,202 - $68,670	-7,948 Reduced 37.74%	13,110 $85,000
Q1 2018 May 15, 2018	SELL	$3.7 - $6.09 $144,248 - $237,424	-38,986 Reduced 64.93%	21,058 $123,000
Q4 2017 Feb 14, 2018	BUY	$2.66 - $3.71 $115,329 - $160,854	43,357 Added 259.83%	60,044 $211,000
Q3 2017 Nov 14, 2017	BUY	$3.58 - $4.34 $59,739 - $72,421	16,687	16,687 $60,000

Ticker CLBS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,583,200
Market Cap $25.8M
Description
Caladrius Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue. Its product candidates include HONEDRA, a recipient of SAKIGAKE designation that is in Phase II clinical trial for the treatment of critical li...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.